Enzalutamide
| CAS No. | 915087-33-1 |
|---|---|
| MDL No. | MFCD14155804 |
| MF | C21H16F4N4O2S |
| MW | 464.40 |
| InChI Key | WXCXUHSOUPDCQV-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Enzalutamide is a benzamide formed by the formal condensation of the carboxy group of 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluorobenzoic acid with methylamine. It is used in the treatment of metastatic castration-resistant prostate cancer. Enzalutamide functions as an antineoplastic agent and androgen antagonist. It belongs to the classes of benzamides, imidazolidinones, thiocarbonyl compounds, nitriles, (trifluoromethyl)benzenes, and monofluorobenzenes.
| CAS No. | 915087-33-1 |
|---|---|
| Product Name | Enzalutamide |
Biological Targets
AR
Associated Conditions
metastatic prostate cancer·prostate cancer·uterine corpus cancer·liver disease·kidney disease·
* The information provided here is compiled from public sources and is for reference only.
